Replies to post #21993 on Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[leifsmith]

Right. This is no ordinary phase 1 trial. It goes far beyond and will produce the kind of results expected from a phase 3 because it measures a therapeutic effect, one known to be beneficial in many disease states.

However, since the therapeutic effect to be measured is reduction of inflammation, and not the consequence of inflammation in any specific disease, it seems that more trials, targeting specific diseases, will be required before a product can be marketed.

The length of such trials, in many cases, might be short.

Do you agree with this?

[knuts4oe]

A masterful explanation of the significance of this phase I trial.

I had been thinking along these lines and wondering if the unusualness of this phase I study was the reason why it took so long to get the phase I study approved.

If your assessment is anywhere near accurate then Rock Creek will have no problem finding the money it needs to complete the study.